855 Future risk for intermediate and high risk prostate cancer in men with baseline PSA of 1-2.99ng/ml and low free-to-total PSA-ratio in a prospective population-based screening trial

✍ Scribed by Randazzo, M.; Beatrice, J.; Huber, A.; Grobholz, R.; Manka, L.; Recker, F.; Kwiatkowski, M.; ERPSC,

• Book ID: 122313556
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 200 KB
• Volume: 13
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(14)60842-3